Position in NVAX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$629,604
-$518,827 QoQ
Shares Held
66,837
-52.6% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 263 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. NVAX ranks #96 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in NVAX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $629,604 | 66,837 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,148,431 | 141,085 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $6,561,327 | 976,388 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $7,964,981 | 918,683 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $5,686,921 | 902,686 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $5,998,561 | 935,813 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,318,094 | 1,158,967 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $14,578,505 | 1,154,276 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $1,404,158 | 110,913 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,712,176 | 358,196 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $823,766 | 171,618 | Shares | Sole | 2024-01-12 | |
| 2023-06-30 | $81,685 | 10,994 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $2,149,651 | 310,195 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,277,896 | 124,309 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $581,399 | 31,945 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $815,936 | 15,865 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $3,596,845 | 48,837 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $511,475 | 3,575 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $6,263,457 | 30,213 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $2,872,341 | 13,529 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $922,142 | 5,086 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,582,460 | 23,159 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $1,216,445 | 11,227 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,617,906 | 19,411 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $155,232 | 11,431 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||